Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 3;396(10256):953-954.
doi: 10.1016/S0140-6736(20)32019-5.

Remdesivir and COVID-19

Lei-Yun Wang  1 , Jia-Jia Cui  1 , Qian-Ying Ouyang  1 , Yan Zhan  1 , Cheng-Xian Guo  2 , Ji-Ye Yin  3
Affiliations
Comment

Remdesivir and COVID-19

Lei-Yun Wang et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment in

  • Remdesivir and COVID-19 - Authors' reply.
    Wang Y, Gu X, Xu J, Cao B, Wang C. Wang Y, et al. Lancet. 2020 Oct 3;396(10256):954. doi: 10.1016/S0140-6736(20)32015-8. Lancet. 2020. PMID: 33010835 Free PMC article. No abstract available.

Comment on

  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Wang Y, et al. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Lancet. 2020. PMID: 32423584 Free PMC article. Clinical Trial.

References

    1. Wang Y, Zhang D, Du G. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569–1578. - PMC - PubMed
    1. US Food & Drug Administration Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. May 1, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19...
    1. Reynolds I. Japan approves Gilead's remdesivir to treat COVID-19 cases. May 7, 2020. https://www.bloomberg.com/news/articles/2020-05-07/japan-set-to-approve-...
    1. Beigel JG, Tomashek KM, Dodd LE. Remdesivir for the treatment of COVID-19—a preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2007764. published online May 22. (2020) - DOI - PubMed
    1. Karczewski KJ, Francioli LC, Tiao J. The mutational constraint spectrum quantified from variation in 141 456 humans. Nature. 2020;581:434–443. - PMC - PubMed